Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Molina-Cerrillo

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Cancers|February 15, 2022
Bronchial Carcinoids: From Molecular Background to Treatment ApproachMarta Araujo-Castro, Eider Pascual-Corrales, Javier Molina-Cerrillo, et al.
Endocrine Oncology (Bristol, England)|January 17, 2025
Everything you ever wanted to know about cancer stem cells in neuroendocrine neoplasms but were afraid to askIgnacio Ruz-Caracuel, Sergio Pedraza-Arevalo, Teresa Alonso-Gordoa, et al.
International Journal of Molecular Sciences|April 20, 2019
Targeting Tyrosine kinases in Renal Cell Carcinoma: "New Bullets against Old Guys"Teresa Alonso-Gordoa, María Laura García-Bermejo, Enrique Grande, et al.
European Journal of Internal Medicine|May 28, 2019
New oncologic emergencies: What is there to know about inmunotherapy and its potential side effects?Arantzazu Barquín-García, Javier Molina-Cerrillo, Pilar Garrido, et al.
International Journal of Molecular Sciences|October 11, 2019
Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance MechanismsJavier Pozas, María San Román, Teresa Alonso-Gordoa, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 24, 2022
Novel therapeutic approaches in GEP-NETs based on genetic and epigenetic alterationsJavier Pozas, Teresa Alonso-Gordoa, Maria San Román, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
PARP Inhibitors for Metastatic CRPC: More Answers than Questions, a Systematic Review and Meta-AnalysisRay Manneh, Javier Molina-Cerrillo, Guillermo de Velasco, et al.
Clinical and Experimental Medicine|September 30, 2021
Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseasesMarta Araujo-Castro, Lía Nattero Chavez, Alberto Martínez Lorca, et al.
Clinical Genitourinary Cancer|June 2, 2015
Primary Sarcomatoid Tumor of the Bladder: A Different Entity but the Same Approach?Javier Molina-Cerrillo, Olga Martínez-Sáez, Teresa Alonso-Gordoa, et al.
Cancer Treatment Reviews|April 5, 2025
Expert consensus on patterns of progression in kidney cancer after adjuvant immunotherapy and subsequent treatment strategiesTeresa Alonso-Gordoa, Georgia Anguera, Mario Domínguez-Esteban, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Cancers|February 15, 2022
Bronchial Carcinoids: From Molecular Background to Treatment ApproachMarta Araujo-Castro, Eider Pascual-Corrales, Javier Molina-Cerrillo, et al.
Endocrine Oncology (Bristol, England)|January 17, 2025
Everything you ever wanted to know about cancer stem cells in neuroendocrine neoplasms but were afraid to askIgnacio Ruz-Caracuel, Sergio Pedraza-Arevalo, Teresa Alonso-Gordoa, et al.
International Journal of Molecular Sciences|April 20, 2019
Targeting Tyrosine kinases in Renal Cell Carcinoma: "New Bullets against Old Guys"Teresa Alonso-Gordoa, María Laura García-Bermejo, Enrique Grande, et al.
European Journal of Internal Medicine|May 28, 2019
New oncologic emergencies: What is there to know about inmunotherapy and its potential side effects?Arantzazu Barquín-García, Javier Molina-Cerrillo, Pilar Garrido, et al.
International Journal of Molecular Sciences|October 11, 2019
Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance MechanismsJavier Pozas, María San Román, Teresa Alonso-Gordoa, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 24, 2022
Novel therapeutic approaches in GEP-NETs based on genetic and epigenetic alterationsJavier Pozas, Teresa Alonso-Gordoa, Maria San Román, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
PARP Inhibitors for Metastatic CRPC: More Answers than Questions, a Systematic Review and Meta-AnalysisRay Manneh, Javier Molina-Cerrillo, Guillermo de Velasco, et al.
Clinical and Experimental Medicine|September 30, 2021
Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseasesMarta Araujo-Castro, Lía Nattero Chavez, Alberto Martínez Lorca, et al.
Clinical Genitourinary Cancer|June 2, 2015
Primary Sarcomatoid Tumor of the Bladder: A Different Entity but the Same Approach?Javier Molina-Cerrillo, Olga Martínez-Sáez, Teresa Alonso-Gordoa, et al.
Cancer Treatment Reviews|April 5, 2025
Expert consensus on patterns of progression in kidney cancer after adjuvant immunotherapy and subsequent treatment strategiesTeresa Alonso-Gordoa, Georgia Anguera, Mario Domínguez-Esteban, et al.
Pageof 10